(Q37662510)

21 August 2017

1 reference

title

Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations (English)

1 reference

juvenile myelomonocytic leukemia

21 August 2017

0 references

1 reference

1 reference

1 reference

Ayami Yoshimi

1

1 reference

21 August 2017

Seiji Kojima

series ordinal

2

1 reference

21 August 2017

Naoto Hirano

series ordinal

3

1 reference

21 August 2017

1 January 2010

1 reference

21 August 2017

1 reference

21 August 2017

12

1 reference

21 August 2017

1

1 reference

21 August 2017

11-21

1 reference

https://scigraph.springernature.com/pub.10.2165/11316200-000000000-00000

21 August 2017

0 references

cites work

Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11316200-000000000-00000

Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11316200-000000000-00000

Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11316200-000000000-00000

Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)

21 January 2018

1 reference

12 December 2020

Results of intensive chemotherapy in children with juvenile chronic myelomonocytic leukemia: a pilot study

1 reference

12 December 2020

Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia

1 reference

12 December 2020

Differentiating juvenile myelomonocytic leukemia from infectious disease

1 reference

12 December 2020

Inhibition of proliferation and induction of apoptosis in juvenile myelomonocytic leukemic cells by the granulocyte-macrophage colony-stimulating factor analogue E21R

1 reference

12 December 2020

Wiskott-Aldrich syndrome is an important differential diagnosis in male infants with juvenile myelomonocytic leukemialike features

1 reference

12 December 2020

Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder

1 reference

12 December 2020

Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia.

1 reference

12 December 2020

Germline KRAS mutations cause Noonan syndrome

1 reference

12 December 2020

RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)

1 reference

12 December 2020

A Pilot Study of Isotretinoin in the Treatment of Juvenile Chronic Myelogenous Leukemia

1 reference

12 December 2020

Juvenile myelomonocytic leukemia and Noonan syndrome

1 reference

12 December 2020

The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease

1 reference

12 December 2020

PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase

1 reference

12 December 2020

Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood

1 reference

12 December 2020

Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan

1 reference

12 December 2020

Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival

1 reference

12 December 2020

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

1 reference

12 December 2020

Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients.

1 reference

12 December 2020

Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors

1 reference

12 December 2020

Analysis of neurofibromatosis type 1 gene mutation in juvenile chronic myelogenous leukemia.

1 reference

12 December 2020

Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria

1 reference

12 December 2020

Molecular mechanisms of action of bisphosphonates: current status.

1 reference

12 December 2020

RAS-blocking bisphosphonate zoledronic acid inhibits the abnormal proliferation and differentiation of juvenile myelomonocytic leukemia cells in vitro.

1 reference

12 December 2020

Identification of an immunogenic CD8+ T-cell epitope derived from gamma-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemia

1 reference

12 December 2020

Juvenile myelomonocytic leukemia: analyses of treatment results in the EORTC Children's Leukemia Cooperative Group (CLCG)

1 reference

12 December 2020

Juvenile myelomonocytic leukemia

1 reference

12 December 2020

Interferon-alpha-2 (IFN) plus hydroxyurea for treatment of juvenile chronic myelogenous leukemia

1 reference

12 December 2020

1 reference

12 December 2020

Atypical cellular disorders

1 reference

12 December 2020

The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia

1 reference

12 December 2020

Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.

1 reference

12 December 2020

Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group.

1 reference

12 December 2020

Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations

1 reference

12 December 2020

The GTPase superfamily: a conserved switch for diverse cell functions

1 reference

12 December 2020

Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders

1 reference

12 December 2020

Isotretinoin for juvenile chronic myelogenous leukemia.

1 reference

12 December 2020

Mutations of the N-ras gene in juvenile chronic myelogenous leukemia

1 reference

12 December 2020

Noonan syndrome and related disorders: alterations in growth and puberty

1 reference

12 December 2020

1 reference

12 December 2020

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

1 reference

12 December 2020

Occurrence of myeloproliferative disorder in patients with Noonan syndrome

1 reference

12 December 2020

A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia

1 reference

12 December 2020

Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.

1 reference

12 December 2020

Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia

1 reference

12 December 2020

Crystal structure of the tyrosine phosphatase SHP-2

1 reference

12 December 2020

Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies

1 reference

12 December 2020

Natural history and early diagnosis of LAD-1/variant syndrome

1 reference

12 December 2020

Germline gain-of-function mutations in SOS1 cause Noonan syndrome

1 reference

12 December 2020

Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.

1 reference

12 December 2020

Neurofibromatosis and childhood leukemia

1 reference

12 December 2020

Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder

1 reference

12 December 2020

Little response to zoledronic acid in a child of juvenile myelomonocytic leukemia (JMML) harboring the PTPN11 mutation

1 reference

12 December 2020

Mutation analysis of Son of Sevenless in juvenile myelomonocytic leukemia

1 reference

12 December 2020

Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis

1 reference

12 December 2020

Juvenile myelomonocytic leukemia

1 reference

12 December 2020

Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children.

1 reference

12 December 2020

Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia

1 reference

12 December 2020

Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia

1 reference

12 December 2020

Diphtheria toxin fused to granulocyte-macrophage colony-stimulating factor is toxic to blasts from patients with juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia

1 reference

12 December 2020

Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors

1 reference

12 December 2020

Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia

1 reference

12 December 2020

Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy

1 reference

12 December 2020

The neurofibromatosis type 1 gene encodes a protein related to GAP

1 reference

12 December 2020

Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.

1 reference

12 December 2020

Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia.

1 reference

12 December 2020

Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction

1 reference

12 December 2020

Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.

1 reference

12 December 2020

Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4

1 reference

12 December 2020

Spontaneous remission of juvenile chronic myelomonocytic leukemia in an infant with Noonan syndrome

1 reference

12 December 2020

Transient response to alpha-interferon in juvenile chronic myelomonocytic leukemia

1 reference

12 December 2020

Inhibition of granulocyte-macrophage colony-stimulating factor prevents dissemination and induces remission of juvenile myelomonocytic leukemia in engrafted immunodeficient mice

1 reference

12 December 2020

Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.

1 reference

12 December 2020

Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells

1 reference

12 December 2020

Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?

1 reference

12 December 2020

Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay

1 reference

12 December 2020

Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors

1 reference

12 December 2020

Germline gain-of-function mutations in RAF1 cause Noonan syndrome

1 reference

12 December 2020

10.2165/11316200-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

0 references

1 reference